Literature DB >> 8184040

Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.

S H Heywang-Köbrunner1, J Haustein, C Pohl, R Beck, B Lommatzsch, M Untch, W B Nathrath.   

Abstract

PURPOSE: To optimize detection and diagnosis of breast lesions with contrast-enhanced magnetic resonance (MR) imaging.
MATERIALS AND METHODS: A three-dimensional fast low-angle shot pulse sequence was used for a group comparison consisting of 76 high-dose (0.16 mmol gadopentetate dimeglumine per kilogram of body weight) and 76 low-dose (0.1 mmol/kg) examinations. Intraindividual comparisons were possible in a subgroup of 20 patients.
RESULTS: Enhancement with the high dose was about 1.5 times higher for benign and malignant tissues. With the lower dose, no false-positive findings could be avoided and definition of a threshold that excluded false-negative findings was problematic. Conspicuity of malignant lesions was much improved with the higher dose (a good to excellent rating in 81% vs 26% with the lower dose). Three small foci were visible only with the higher dose.
CONCLUSION: The higher dose of contrast material allowed much better results. Dose comparison studies are also recommended for other techniques.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8184040     DOI: 10.1148/radiology.191.3.8184040

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Effects of partial volume and phase shift between fat and water in gradient-echo magnetic resonance-mammography.

Authors:  M Peller; M K Stehling; H Sittek; M Kessler; M Reiser
Journal:  MAGMA       Date:  1996-06       Impact factor: 2.310

2.  Preliminary study: Breast cancers can be well seen on 3T breast MRI with a half-dose of gadobutrol.

Authors:  Amy N Melsaether; Eric Kim; Eralda Mema; James Babb; Sungheon Gene Kim
Journal:  Clin Imaging       Date:  2019-06-27       Impact factor: 1.605

3.  Dynamic contrast-enhanced MR imaging of the entire breast with spectral-selective inversion fast three dimensional sequence.

Authors:  M Goto; H Sakuma; S Kobayashi; K Matsumura; K Takeda
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

4.  Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model.

Authors:  Menglin Wu; Li Lu; Qi Zhang; Qi Guo; Feixiang Zhao; Tongwei Li; Xuening Zhang
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

5.  The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.

Authors:  Jing Yuan; Steven Kwok Keung Chow; Qinwei Zhang; David Ka Wai Yeung; Anil T Ahuja; Ann D King
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

6.  Breast MRI: guidelines from the European Society of Breast Imaging.

Authors:  R M Mann; C K Kuhl; K Kinkel; C Boetes
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

7.  Effect of contrast dose on diagnostic performance in DCE-MR breast imaging.

Authors:  Thuy-My Thi Le; Elizabeth S McDonald; Gamaliel Isaac; Mark A Rosen; Lawrence Dougherty
Journal:  J Appl Clin Med Phys       Date:  2020-10-22       Impact factor: 2.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.